Transforming the screening
and management of

diabetic eye disease.

Asset 11_4x.png
Close up of woman eye in process of scanning.jpg

GLOBAL DIABETES

500 million adults suffer
from diabetes worldwide

Asset 48_4x.png

51% projected increase in global diabetes by 2045

1out of 3 diabetics
develop diabetic retinopathy

WHAT WE DO

Early Detection

Oivi’s product and service allows for early detection of diabetic retinopathy; reducing the number of people who suffer permanent loss of vision.

Primary Health Center Konnankunte Bangal
Asset 10_4x.png

Rapid Diagnosis

Oivi drastically reduces time to

diagnosis, our intelligent camera and seamless service model shortens

time to treatment thereby reducing costs

for both patients and healthcare systems.

Point-of-need Care

Oivi enables diagnosis at the

point-of-need, reaching high-risk

diabetic patients right where ever

they may be located.

IMG_3977.jpg
Asset 11_4x.png
IMG_4090.jpg

Expanding screening for eye diseases from
specialist clinics to primary care clinics

Asset 31_4x.png

PRIMARY CARE CENTRES

Asset 33_4x.png

DIABETES CLINICS

Asset 32_4x.png

PHARMACIES

Asset 35_4x.png

EYE HOSPITALS

Asset 11_4x_edited.png

OUR SUPPORT

rcn_2-2_edited.jpg
medlim-logo-rgb_edited.png
NicePng_extreme-png_9764918_edited.png
59dbff22f9dd8c4d64e86541-fa9a1e-2_edited
61284_web-2_edited_edited.jpg
Logo_of_L._V._Prasad_Eye_Institute.jpg
logoSINTEF_edited.png
orglogo_edited.jpg
st-johns-medical-college-hospital_edited
Asset 11_4x_edited.png

Find out more about Oivi

THE TEAM

Anders.jpg

Anders Eikenes

CEO & CO-FOUNDER

khaleel-Oivi_edited.jpg

Khaleel Udyawar

CTO & CO-FOUNDER

jukka.jpg

Jukka Alasirnio

COO & CO-FOUNDER

Asset 10_4x.png